In summary, BAO mitigates KA-induced epilepsy-like behaviors by modulating the Bcl2/Bax/caspase-3 signaling pathway and the Notch1/GABA/GAD/GIRK signaling pathway, thereby playing a therapeutic role in epilepsy. The gene discussed is BCL2; the disease is epilepsy.